Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States, in France, in Canada, .... It focuses on depression.
In United StatesThis study is comparing CTC-501 with placebo for people with depression. Participants receive CTC-501 or placebo and complete study visits and assessments.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study is completed in the United States. It focuses on schizophrenia.
In United States
This study is active but not recruiting in the United States. It is testing N, N-dimethyltryptamine (DMT) Analog for anxiety.
In United StatesThis study is completed in the United States. It is testing aripiprazole for depression.
In United StatesThis study is completed in the United States. It is testing treatment Of Cognitive Deficits for schizophrenia.
In United StatesThis study is completed in the United States, in Bulgaria, in Serbia, .... It is testing ALKS 3831 for schizophrenia.
In United StatesThis study is completed in the United States, in Bulgaria, and in Czechia. It is testing ALKS 3831 for schizophrenia.
In United StatesThis study is completed in the United States. It is testing ALKS 3831 for schizophrenia.
In United StatesThis study is completed in the United States, in Bulgaria, and in Poland. It is testing ALKS 3831 for schizophrenia.
In United StatesThis study is completed in the United States. It is testing ALKS 9072 for schizophrenia.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.